Quantcast

Latest ESRD Stories

2010-11-03 11:43:00

Providers Call on Government Officials to Set Payment Levels Based on Actual Number of Facilities, Rather Than Estimates WASHINGTON, Nov. 3, 2010 /PRNewswire-USNewswire/ -- The Kidney Care Council (KCC), a nonprofit national health care association composed of leading kidney dialysis provider companies who care for a majority of ESRD patients nationwide, released new data today revealing that 98 percent of kidney care providers participating in a recent study have opted to participate in...

2010-09-29 07:30:00

NEW YORK, Sept. 29 /PRNewswire/ --Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today the initiation of the long-term Phase 3 study of Zerenex(TM) (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis. The initiation of this study marks the commencement of the final component of the Company's Phase 3 registration program for Zerenex,...

2010-04-15 07:30:00

NEW YORK, April 15 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today reported updated long-term efficacy and safety data on Zerenex(TM) (ferric citrate), the Company's iron-based phosphate binder for the treatment of hyperphosphatemia (elevated phosphate levels) from an open-label extension study in patients with end-stage renal disease (ESRD) who are on dialysis. This data was presented yesterday at the National Kidney Foundation (NKF) 2010 Spring Clinical...

2010-03-11 14:20:00

Mourning Joins Kidney Care Partners to Emphasize Kidney Disease Education, Improved Patient Choice for Dialysis Care and Access to Transplant Medications WASHINGTON, March 11 /PRNewswire-USNewswire/ -- Seven-time NBA All-Star Alonzo Mourning today joined Kidney Care Partners (KCP) - an alliance of patient advocates, dialysis professionals, providers and manufacturers working together to improve the quality of care for individuals with end stage renal disease (ESRD) - to call attention to...

2010-02-25 12:27:00

RIVER EDGE, N.J., Feb. 25 /PRNewswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that is has signed an exclusive distribution agreement with Bellco Health Care Inc. ("BHC Medical") to sell and market Nephros' OLpur(TM) MD 220 filter for on-line HDF therapy in Canada. Under the terms of the Agreement, Nephros and BHC...

2009-10-30 17:01:43

Future studies will tell whether raising vitamin D Levels can slow kidney disease Low levels of vitamin D may account for nearly 60 percent of the elevated risk of end-stage renal disease (ESRD) in African Americans, according to a report in the December Journal of the American Society of Nephrology (JASN). "Our study adds to previous evidence linking vitamin D deficiency to the progression of kidney disease and the need for dialysis," comments Michal L. Melamed, MD, of Albert Einstein...

2009-10-12 13:20:00

NBA-All Star Alonzo Mourning, Kidney Care Partners Call Attention to Extended Medicare Secondary Payer Policy as Cost-Saving Reform to Improve Patient Access to Quality Care WASHINGTON, Oct. 12 /PRNewswire-USNewswire/ -- Kidney Care Partners - an alliance of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with kidney disease and kidney failure - today applauded the Congressional Black Caucus...

2009-10-12 13:56:00

Mourning Builds on Recent Florida Legislative Victory for Kidney Patients, Promotes National Policies to Build on Quality Improvements, Enhance Patients' Access to Care MIAMI, Oct. 12 /PRNewswire-USNewswire/ -- Seven-time NBA All-Star and kidney transplant recipient Alonzo Mourning visited Washington, D.C. this week to meet with federal lawmakers - including House Speaker Nancy Pelosi (D-CA), the Congressional Black Caucus (CBC) and other House and Senate leaders - to educate them...

2009-06-08 07:30:00

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced results of the Phase 2 study of Zerenex (ferric citrate) for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on thrice weekly hemodialysis. The study was a multicenter, open-label clinical trial, which enrolled 55 patients. The primary objective of this study was to assess the tolerability and safety of Zerenex...

2009-04-09 09:36:53

Study suggests that GFR and albuminuria tests should be performed on all chronic kidney disease patients Measuring kidney function by assessing two different factors"”glomerular filtration rate (GFR) and urinary albumin levels"”helps determine which patients with chronic kidney disease (CKD) will develop end-stage renal disease (ESRD), according to a study appearing in the May 2009 issue of the Journal of the American Society Nephrology (JASN). This combination test could help...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related